Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.

Identifieur interne : 002A57 ( PubMed/Corpus ); précédent : 002A56; suivant : 002A58

Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.

Auteurs : Hideaki Matsui ; Kazuto Nishinaka ; Masaya Oda ; Narihiro Hara ; Kenichi Komatsu ; Tamotsu Kubori ; Fukashi Udaka

Source :

RBID : pubmed:17029260

English descriptors

Abstract

We examined patients with and without auditory hallucinations, using n-isopropyl-p-[123I]iodoamphetamine single photon emission computed tomographic imaging. We assessed verbal hallucinations in the present study: patients with nonverbal auditory hallucinations were excluded. A total of 11 patients with verbal and visual hallucinations and 17 patients with visual hallucinations only were enrolled. Patients with both verbal and visual hallucinations revealed significant hypoperfusion in the bilateral prefrontal cortex and right superior temporal gyrus compared to patients with visual hallucinations only. There were no significant hyperperfusion in patients with verbal plus visual hallucinations. These results may support the release hallucination theory in verbal hallucinations of Parkinson's disease, although another explanations may be more appropriate and further studies are required.

DOI: 10.1002/mds.21147
PubMed: 17029260

Links to Exploration step

pubmed:17029260

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.</title>
<author>
<name sortKey="Matsui, Hideaki" sort="Matsui, Hideaki" uniqKey="Matsui H" first="Hideaki" last="Matsui">Hideaki Matsui</name>
<affiliation>
<nlm:affiliation>Department of Neurology, Sumitomo Hospital, Kita-ku, Osaka, Japan. matsui-hideaki@sumitomo-hp.or.jp</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nishinaka, Kazuto" sort="Nishinaka, Kazuto" uniqKey="Nishinaka K" first="Kazuto" last="Nishinaka">Kazuto Nishinaka</name>
</author>
<author>
<name sortKey="Oda, Masaya" sort="Oda, Masaya" uniqKey="Oda M" first="Masaya" last="Oda">Masaya Oda</name>
</author>
<author>
<name sortKey="Hara, Narihiro" sort="Hara, Narihiro" uniqKey="Hara N" first="Narihiro" last="Hara">Narihiro Hara</name>
</author>
<author>
<name sortKey="Komatsu, Kenichi" sort="Komatsu, Kenichi" uniqKey="Komatsu K" first="Kenichi" last="Komatsu">Kenichi Komatsu</name>
</author>
<author>
<name sortKey="Kubori, Tamotsu" sort="Kubori, Tamotsu" uniqKey="Kubori T" first="Tamotsu" last="Kubori">Tamotsu Kubori</name>
</author>
<author>
<name sortKey="Udaka, Fukashi" sort="Udaka, Fukashi" uniqKey="Udaka F" first="Fukashi" last="Udaka">Fukashi Udaka</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="doi">10.1002/mds.21147</idno>
<idno type="RBID">pubmed:17029260</idno>
<idno type="pmid">17029260</idno>
<idno type="wicri:Area/PubMed/Corpus">002A57</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.</title>
<author>
<name sortKey="Matsui, Hideaki" sort="Matsui, Hideaki" uniqKey="Matsui H" first="Hideaki" last="Matsui">Hideaki Matsui</name>
<affiliation>
<nlm:affiliation>Department of Neurology, Sumitomo Hospital, Kita-ku, Osaka, Japan. matsui-hideaki@sumitomo-hp.or.jp</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nishinaka, Kazuto" sort="Nishinaka, Kazuto" uniqKey="Nishinaka K" first="Kazuto" last="Nishinaka">Kazuto Nishinaka</name>
</author>
<author>
<name sortKey="Oda, Masaya" sort="Oda, Masaya" uniqKey="Oda M" first="Masaya" last="Oda">Masaya Oda</name>
</author>
<author>
<name sortKey="Hara, Narihiro" sort="Hara, Narihiro" uniqKey="Hara N" first="Narihiro" last="Hara">Narihiro Hara</name>
</author>
<author>
<name sortKey="Komatsu, Kenichi" sort="Komatsu, Kenichi" uniqKey="Komatsu K" first="Kenichi" last="Komatsu">Kenichi Komatsu</name>
</author>
<author>
<name sortKey="Kubori, Tamotsu" sort="Kubori, Tamotsu" uniqKey="Kubori T" first="Tamotsu" last="Kubori">Tamotsu Kubori</name>
</author>
<author>
<name sortKey="Udaka, Fukashi" sort="Udaka, Fukashi" uniqKey="Udaka F" first="Fukashi" last="Udaka">Fukashi Udaka</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint>
<date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Auditory Cortex (radionuclide imaging)</term>
<term>Female</term>
<term>Hallucinations (etiology)</term>
<term>Hallucinations (pathology)</term>
<term>Hallucinations (radionuclide imaging)</term>
<term>Humans</term>
<term>Imaging, Three-Dimensional (methods)</term>
<term>Iofetamine (diagnostic use)</term>
<term>Male</term>
<term>Mental Status Schedule</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson Disease (radionuclide imaging)</term>
<term>Prefrontal Cortex (radionuclide imaging)</term>
<term>Radiopharmaceuticals (diagnostic use)</term>
<term>Severity of Illness Index</term>
<term>Tomography, Emission-Computed, Single-Photon (methods)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en">
<term>Iofetamine</term>
<term>Radiopharmaceuticals</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Hallucinations</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Imaging, Three-Dimensional</term>
<term>Tomography, Emission-Computed, Single-Photon</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Hallucinations</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en">
<term>Auditory Cortex</term>
<term>Hallucinations</term>
<term>Parkinson Disease</term>
<term>Prefrontal Cortex</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Mental Status Schedule</term>
<term>Severity of Illness Index</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We examined patients with and without auditory hallucinations, using n-isopropyl-p-[123I]iodoamphetamine single photon emission computed tomographic imaging. We assessed verbal hallucinations in the present study: patients with nonverbal auditory hallucinations were excluded. A total of 11 patients with verbal and visual hallucinations and 17 patients with visual hallucinations only were enrolled. Patients with both verbal and visual hallucinations revealed significant hypoperfusion in the bilateral prefrontal cortex and right superior temporal gyrus compared to patients with visual hallucinations only. There were no significant hyperperfusion in patients with verbal plus visual hallucinations. These results may support the release hallucination theory in verbal hallucinations of Parkinson's disease, although another explanations may be more appropriate and further studies are required.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">17029260</PMID>
<DateCreated>
<Year>2006</Year>
<Month>12</Month>
<Day>27</Day>
</DateCreated>
<DateCompleted>
<Year>2007</Year>
<Month>02</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>21</Volume>
<Issue>12</Issue>
<PubDate>
<Year>2006</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.</ArticleTitle>
<Pagination>
<MedlinePgn>2165-9</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We examined patients with and without auditory hallucinations, using n-isopropyl-p-[123I]iodoamphetamine single photon emission computed tomographic imaging. We assessed verbal hallucinations in the present study: patients with nonverbal auditory hallucinations were excluded. A total of 11 patients with verbal and visual hallucinations and 17 patients with visual hallucinations only were enrolled. Patients with both verbal and visual hallucinations revealed significant hypoperfusion in the bilateral prefrontal cortex and right superior temporal gyrus compared to patients with visual hallucinations only. There were no significant hyperperfusion in patients with verbal plus visual hallucinations. These results may support the release hallucination theory in verbal hallucinations of Parkinson's disease, although another explanations may be more appropriate and further studies are required.</AbstractText>
<CopyrightInformation>Copyright 2006 Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Matsui</LastName>
<ForeName>Hideaki</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurology, Sumitomo Hospital, Kita-ku, Osaka, Japan. matsui-hideaki@sumitomo-hp.or.jp</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nishinaka</LastName>
<ForeName>Kazuto</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oda</LastName>
<ForeName>Masaya</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hara</LastName>
<ForeName>Narihiro</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Komatsu</LastName>
<ForeName>Kenichi</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Kubori</LastName>
<ForeName>Tamotsu</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Udaka</LastName>
<ForeName>Fukashi</ForeName>
<Initials>F</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019275">Radiopharmaceuticals</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>C2A5X08042</RegistryNumber>
<NameOfSubstance UI="D020367">Iofetamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001303">Auditory Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006212">Hallucinations</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D021621">Imaging, Three-Dimensional</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D020367">Iofetamine</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008609">Mental Status Schedule</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000473">pathology</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D017397">Prefrontal Cortex</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000531">radionuclide imaging</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D019275">Radiopharmaceuticals</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000176">diagnostic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D012720">Severity of Illness Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015899">Tomography, Emission-Computed, Single-Photon</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000379">methods</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2006</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>2</Month>
<Day>21</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2006</Year>
<Month>10</Month>
<Day>10</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1002/mds.21147</ArticleId>
<ArticleId IdType="pubmed">17029260</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002A57 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002A57 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:17029260
   |texte=   Hypoperfusion of the auditory and prefrontal cortices in Parkinsonian patients with verbal hallucinations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:17029260" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024